Skopos Labs, Inc. Elanco Animal Health Inc Transaction History
Skopos Labs, Inc.
- $497 Million
- Q2 2025
A detailed history of Skopos Labs, Inc. transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Skopos Labs, Inc. holds 1,103 shares of ELAN stock, worth $23,703. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,103
Previous 1,103
-0.0%
Holding current value
$23,703
Previous $11,000
36.36%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ELAN
# of Institutions
444Shares Held
492MCall Options Held
868KPut Options Held
1.42M-
Dodge & Cox San Francisco, CA82.9MShares$1.78 Billion0.71% of portfolio
-
Primecap Management CO Pasadena, CA51.8MShares$1.11 Billion0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.6MShares$1.04 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$501 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX22.7MShares$489 Million0.08% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $10.2B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...